Should we provide outreach rehabilitation to very old people living in Nursing Care Facilities after a hip fracture? A randomised controlled trial.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 20 05 2018
revised: 11 12 2018
accepted: 22 01 2019
pubmed: 23 2 2019
medline: 12 5 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

to determine whether a 4-week postoperative rehabilitation program delivered in Nursing Care Facilities (NCFs) would improve quality of life and mobility compared with receiving usual care. parallel randomised controlled trial with integrated health economic study. NCFs, in Adelaide South Australia. people aged 70 years and older who were recovering from hip fracture surgery and were walking prior to hip fracture. primary outcomes: mobility (Nursing Home Life-Space Diameter (NHLSD)) and quality of life (DEMQOL) at 4 weeks and 12 months. participants were randomised to treatment (n = 121) or control (n = 119) groups. At 4 weeks, the treatment group had better mobility (NHLSD mean difference -1.9; 95% CI: -3.3, -0.57; P = 0.0055) and were more likely to be alive (log rank test P = 0.048) but there were no differences in quality of life. At 12 months, the treatment group had better quality of life (DEMQOL sum score mean difference = -7.4; 95% CI: -12.5 to -2.3; P = 0.0051), but there were no other differences between treatment and control groups. Quality adjusted life years (QALYs) gained over 12 months were 0.0063 higher per participant (95% CI: -0.0547 to 0.0686). The resulting incremental cost effectiveness ratios (ICERs) were $5,545 Australian dollars per unit increase in the NHLSD (95% CI: $244 to $15,159) and $328,685 per QALY gained (95% CI: $82,654 to $75,007,056). the benefits did not persist once the rehabilitation program ended but quality of life at 12 months in survivors was slightly higher. The case for funding outreach home rehabilitation in NCFs is weak from a traditional health economic perspective. ACTRN12612000112864 registered on the Australian and New Zealand Clinical Trials Registry. Trial protocol available at https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id = 361980.

Identifiants

pubmed: 30794284
pii: 5362536
doi: 10.1093/ageing/afz005
pmc: PMC6503935
doi:

Banques de données

ANZCTR
['ACTRN12612000112864']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-380

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Geriatrics Society.

Références

Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
Health Econ. 2018 Jan;27(1):7-22
pubmed: 28833869
J Clin Epidemiol. 1989;42(8):703-9
pubmed: 2760661
J Am Med Dir Assoc. 2003 Jan-Feb;4(1):9-15
pubmed: 12807591
Drugs Aging. 2012 Jan 1;29(1):31-43
pubmed: 22191721
Int J Geriatr Psychiatry. 2015 Apr;30(4):400-8
pubmed: 24920081
Qual Life Res. 2016 Dec;25(12):3107-3118
pubmed: 27318488
Best Pract Res Clin Rheumatol. 2013 Dec;27(6):771-88
pubmed: 24836335
Med Decis Making. 2008 Sep-Oct;28(5):713-22
pubmed: 18378939
Med Care. 2001 Aug;39(8):760-71
pubmed: 11468496
Health Econ. 2018 Jan;27(1):39-49
pubmed: 29063633
Nestle Nutr Workshop Ser Clin Perform Programme. 1999;1:87-91; discussion 91-2
pubmed: 11490599
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
JAMA Intern Med. 2014 Aug;174(8):1273-80
pubmed: 25055155
J Am Geriatr Soc. 2003 Mar;51(3):364-70
pubmed: 12588580
Biol Psychiatry. 1988 Feb 1;23(3):271-84
pubmed: 3337862
Health Technol Assess. 2013 Feb;17(5):v-xv, 1-140
pubmed: 23402232
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004294
pubmed: 23450551
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Value Health. 2011 Mar-Apr;14(2):390-9
pubmed: 21402307
West J Nurs Res. 2007 Aug;29(5):523-44
pubmed: 17526868
J Bone Joint Surg Am. 1994 May;76(5):751-8
pubmed: 8175825
Value Health. 2012 Mar-Apr;15(2):346-56
pubmed: 22433767
Eur J Health Econ. 2015 Nov;16(8):847-55
pubmed: 25252970
J Am Geriatr Soc. 1990 Dec;38(12):1311-5
pubmed: 2254569

Auteurs

Maria Crotty (M)

Rehabilitation, Aged and Extended Care, Flinders University, Finders Medical Centre, Level 4 Rehabilitation Building, Flinders Drive, Bedford Park SA, Australia.

Maggie Killington (M)

Rehabilitation, Aged and Extended Care, Flinders University, Finders Medical Centre, Level 4 Rehabilitation Building, Flinders Drive, Bedford Park SA, Australia.

Enwu Liu (E)

Rehabilitation, Aged and Extended Care, Flinders University, Finders Medical Centre, Level 4 Rehabilitation Building, Flinders Drive, Bedford Park SA, Australia.
Musculoskeletal Health and Ageing Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne Vic, Australia.

Ian D Cameron (ID)

John Walsh Centre for Rehabilitation Research, University of Sydney, Royal North Shore Hospital, St Leonards NSW, Australia.

Susan Kurrle (S)

Cognitive Decline Partnership Centre, University of Sydney, Hornsby Ku-ring-gai Hospital, Hornsby NSW, Australia.

Billingsley Kaambwa (B)

Health Economics Unit, Flinders University, Health Sciences Building, Sturt Road, Bedford Park SA, Australia.

Owen Davies (O)

Rehabilitation, Aged and Extended Care, Flinders University, Finders Medical Centre, Level 4 Rehabilitation Building, Flinders Drive, Bedford Park SA, Australia.

Michelle Miller (M)

Department of Nutrition and Dietetics, College of Nursing and Health Sciences, Flinders University, Bedford Park SA, Australia.

Mellick Chehade (M)

Centre for Orthopaedic Trauma and Research, University of Adelaide, Adelaide SA, Australia.
Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Adelaide SA, Australia.
Centre of Research Excellence in Frailty and Healthy Ageing, University of Adelaide, Adelaide SA, Australia.

Julie Ratcliffe (J)

Health and Social Care Economics Group, Flinders University, Sturt Road, Bedford Park SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH